|

The Effect of Therapy Combination in PCOS With Dlbs 3233

RECRUITINGEarly 1Sponsored by Inlacinpenelitian
Actively Recruiting
PhaseEarly 1
SponsorInlacinpenelitian
Started2021-12-15
Est. completion2026-01-31
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07403201

Summary

The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* married agree to join this research

Exclusion Criteria:

* dis agree to join research

Conditions2

CancerPolycystic Ovary Syndrome

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.